KCT-20755-12396
4 vaccinations
3 coded responses
17 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 106 / NY
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Registered in v-safe
-
2021-04-15
Survey response — day 7, dose 1MedDRA: Menstruation delayed — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Late menstrual cycle (4 days)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-26
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body achesAdult check-in
-
2021-05-01
Health check-in — day 7, dose 2Feeling: Good · Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-05-08
- 2021-05-15
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-10-23
-
2022-04-25
Survey response — 12 months, dose 2MedDRA: Headache, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cold - runny nose, congestion, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Dose 4 — Moderna
- 2022-09-16
-
2022-09-19
Survey response — day 7, dose 4MedDRA: Brain fog — Feeling: Poor · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Brain fogMedDRA releases: 2024-11 · check-in free text available
- 2022-10-10
- 2022-10-17
- 2022-10-26
- 2022-12-14
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-12 | Moderna | No |
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Late menstrual cycle (4 days)
Release 11 — 12 months, dose 2
Symptoms: Cold - runny nose, congestion, headache
Release 12 — day 7, dose 4
Systemic reaction (other): Brain fog
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Menstruation delayed | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release